Skip to main content
Journal ArticleOPEN ACCESS

A single ascending dose study in healthy volunteers to assess the safety and PK of LY3372689, an inhibitor of O‐GlcNAcase (OGA) enzyme

  • Kielbasa W
  • Phipps K
  • Tseng J
  • et al.
Alzheimer's & Dementia (2020) 16(S9)
DOI: 10.1002/alz.040473
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: LY3372689, an O-GlcNAcase (OGA) enzyme inhibitor, is being developed

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kielbasa, W., Phipps, K. M., Tseng, J., Natanegara, F., Cheng, E., Monk, S. A., … Lowe, S. L. (2020). A single ascending dose study in healthy volunteers to assess the safety and PK of LY3372689, an inhibitor of O‐GlcNAcase (OGA) enzyme. Alzheimer’s & Dementia, 16(S9). https://doi.org/10.1002/alz.040473

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

100%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 1

25%

Biochemistry, Genetics and Molecular Bi... 1

25%

Business, Management and Accounting 1

25%

Neuroscience 1

25%

Save time finding and organizing research with Mendeley

Sign up for free